CLINICAL_TRIALS trial_result · 2019-05-09

Clinical Trial Update: Effectiveness of Pulmozyme in Infants With Cystic Fibrosis [Phase 2]

Phase 2 trial update on Pulmozyme (dornase alfa) effectiveness in infants with cystic fibrosis; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Nationwide Children's Hospital | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-09